MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2023 International Congress

    Dystonia Treatment With Injections Supplemented by TMS: the D-TWIST Study

    J. Frey, J. Yu, J. Lobo Lopes, L. Fanty, I. Malaty, A. Ramirez-Zamora, M. Wajid, J. Cagle, C. de Hemptinne, A. Wagle Shukla (Morgantown, USA)

    Objective: To evaluate the safety, feasibility, tolerability and effects of accelerated rTMS for treatment of cervical dystonia. Background: In a subgroup of patients with cervical…
  • 2023 International Congress

    Incidence of dysphagia and comorbidities in patients with cervical dystonia, analyzed by botulinum neurotoxin treatment exposure

    M. Sadeghi, A. Ukah, E. Yue, K. Becker Ifantides, N. Huang, J. Lee, R. Barbano (Irvine, USA)

    Objective: Describe real-world incidence of dysphagia and other comorbidities in adults with cervical dystonia (CD) treated and not treated with botulinum neurotoxin (BoNT). Background: Dysphagia…
  • 2023 International Congress

    Topical Botulinum-Toxin-like Alternatives: A Systematic Literature Review

    S. Maytharakcheep, O. Phokaewvarangkul, R. Bhidayasiri (bangkok, Thailand)

    Objective: To perform a systematic review exploring the relevant literature on BoNT and BoNT-like substances in topical form and clinical trials focusing on facial muscle…
  • 2023 International Congress

    blepharoplasty yes or not? a single-centre study on the influence of blepharoplasty on the treatment with botulinum toxin injections.

    A. Trinchillo, N. Cuomo, F. Iorillo, G. de Joanna, F. Habetswallner, M. Esposito (Giugliano in Campania, Italy)

    Objective: To compare the responses to the BoNT injections of patients who underwent or not to blepharoplasty (Blepharoplasty YES/NO), in order to clarify if the…
  • 2023 International Congress

    Clinical presentation and evolution of isolated focal and segmental dystonia in adults – 20 years experience from a botulinum toxin clinic

    A. Vijayaraghavan, D. Divya, S. Krishnan (Trivandrum, India)

    Objective: To provide unique data on the common patterns of muscles selected for injection and the time course of benefit and weakness for BoNT injections…
  • 2022 International Congress

    Treatment of upper limb dystonic tremors: a retrospective study

    B. Gonzalez-Herrero, I. Di Vico, M. Edwards, F. Morgante (London, United Kingdom)

    Objective: Our study aimed to evaluate the clinical outcome of patients with upper-limb dystonic tremor (UL-DTs) treated at a tertiary hospital in London. Background: Tremor…
  • 2022 International Congress

    Impact of botulinum toxin treatment on gait in focal dystonia

    J. Cuinat, B. Debu, P. Pelissier, A. Castrioto, S. Meoni, S. Potel, V. Fraix, E. Moro (Grenoble, France)

    Objective: To study the effects of botulinum neurotoxin (BTX) treatment on gait characteristics in patients with blepharospasm and cervical dystonia. Background: The impact of focal…
  • 2022 International Congress

    Changes in botulinum toxin dosing in cervical dystonia over 7 years

    S. Rafee, M. Hutchinson (Dublin, Ireland)

    Objective: To assess changes in botulinum toxin dosing over the course of illness of cervical dystonia. Background: Muscle specific botulinum toxin injections remains the main…
  • 2022 International Congress

    Use of bupivacaine in the evaluation of acute secondary cervical dystonia (CD)

    JR. Chai, S. Bansal, C. Li, M. Jog (London, Canada)

    Objective: To highlight the potential use of bupivacaine/analgesics in assessing cervical dystonia, where disabling local pain can be a confounder and limits clinical examination. Background:…
  • 2022 International Congress

    Botulinum Toxin Therapy for Medication and DBS Refractory Foot Dystonia of Parkinsonism

    E. Zinoviev, M. Ganapathy, M. Siddiqui (Winston-Salem, USA)

    Objective: To determine efficacy and safety of BTX therapy in patients with medically refractory foot dystonia secondary to Parkinson’s disease (PD) or atypical Parkinsonism (AP)…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 21
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley